Mirova Dexcom Inc Transaction History

Mirova

$560 Million
Q1 2024

A detailed history of Mirova transactions in Dexcom Inc stock. As of the latest transaction made, Mirova holds 5,628 shares of DXCM stock, worth $624,539. This represents 0.14% of its overall portfolio holdings.

Number of Shares

5,628

Previous 784 617.86%

Holding current value

$624,539

Previous $97,000 704.12%

% of portfolio

0.14%

Previous 0.02%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$114.22 - $140.1 $553,281 - $678,644	4,844 Added 617.86%	5,628 $780,000
Q4 2023 Feb 13, 2024	SELL	$75.49 - $124.16 $3,548 - $5,835	-47 Reduced 5.66%	784 $97,000
Q3 2023 Nov 14, 2023	SELL	$86.06 - $137.93 $121,258 - $194,343	-1,409 Reduced 62.9%	831 $77,000
Q2 2023 Aug 11, 2023	SELL	$112.47 - $130.98 $274,201 - $319,329	-2,438 Reduced 52.12%	2,240 $287,000
Q1 2023 May 12, 2023	BUY	$104.0 - $122.92 $290,368 - $343,192	2,792 Added 148.04%	4,678 $543,000

Q4 2022 Feb 13, 2023	SELL	$84.98 - $122.67 $90,588 - $130,766	-1,066 Reduced 36.11%	1,886 $213,000
Q3 2022 Nov 14, 2022	SELL	$76.35 - $94.18 $689,593 - $850,633	-9,032 Reduced 75.37%	2,952 $237,000
Q2 2022 Aug 12, 2022	BUY	$67.99 - $132.89 $790,247 - $1.54 Million	11,623 Added 3219.67%	11,984 $893,000
Q4 2021 Feb 14, 2022	BUY	$129.87 - $162.82 $46,883 - $58,778	361 New	361 $193,000
Q4 2020 Feb 12, 2021	SELL	$78.0 - $104.5 $3,276 - $4,389	-42 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$95.51 - $112.95 $4,011 - $4,743	42 New	42 $17,000

Others Institutions Holding DXCM

# of Institutions

1,123

Shares Held

353M

Call Options Held

4.19M

Put Options Held

4.54M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $42.9B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirova, based on Form 13F filings with the SEC.

News

Stay updated on Mirova with notifications on news.

Account